Obstructive Sleep Apnea and ROHHAD: Are They Connected?

by Danielle Bradshaw, In the Cloud Copy A common occurrence among children that have rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation or ROHHAD syndrome is that they’re also…

Continue Reading Obstructive Sleep Apnea and ROHHAD: Are They Connected?
A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
source: pixabay.com

A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function

By Lauren Thayer from In The Cloud Copy Latent autoimmune diabetes in adults or LADA is a slow progressing form of autoimmune diabetes. Similar to type 1 diabetes, also an…

Continue Reading A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
source: pixabay.com

Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives

Over 2018 and 2019, BioCryst Pharmaceuticals conducted two surveys to better understand the needs and expectations of hereditary angioedema (HAE) patients. Overall, they found that despite progress in HAE therapies,…

Continue Reading Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a

A study conducted by researchers from Aix-Marseille University in France has revealed a new way to track disease progression of Charcot-Marie-Tooth disease type 1a (CMT1a)- changes to the nerves within the thigh.…

Continue Reading New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a
$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
QuinceMedia / Pixabay

$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Every day, the world becomes increasingly technological. With this comes advances in many realms, from healthcare to education. Recently, says Parkinson's News, medical technology company Manus Neurodynamica received £750,000 (approx. $950,000)…

Continue Reading $950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias
source: pixabay.com

Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

Celldex has just released positive results from a Phase 1 trial of an investigative therapy which could benefit patients living with chronic urticarias. This disease can result in decreased energy,…

Continue Reading Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation

According to Healio, US veterans affected by pulmonary arterial hypertension are typically not treated with exercise rehabilitation, despite the fact that many medical professionals believe that utilizing exercise rehabilitation in…

Continue Reading US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation

This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency

When the 19-year-old French woman first visited the hospital, she was extremely lethargic. She displayed neurological symptoms. Upon kidney failure, the patient was admitted into the ICU. But soon, doctors…

Continue Reading This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency
Expressive Language Sampling May Lead to Treatment Options for Fragile X Syndrome
source: pixabay.com

Expressive Language Sampling May Lead to Treatment Options for Fragile X Syndrome

By Danielle Bradshaw from In The Cloud Copy Expressive language sampling, or ELS, could potentially help researchers better measure how well treatments work for patients with fragile X syndrome or…

Continue Reading Expressive Language Sampling May Lead to Treatment Options for Fragile X Syndrome
Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients